Product information and disease descriptionPlace of product in therapy
Disease description
87 evidence topics · 48 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionPlace of product in therapy
87 evidence topics · 48 sources